Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis
Abstract (provisional)
Background
Hepatectomy is recommended as the best effective therapy for liver metastasis from colorectal cancer (CRCLM). It is crucial to elucidate the prognostic clinicopathological factors.
Methods
Eighty-three patients undergoing initial hepatectomy for CRCLM were retrospectively analyzed with respect to tumor characteristics of primary colorectal and metastatic hepatic tumors, operation details and prognosis.
Results
The overall 5-year survival rate after initial hepatectomy for CRCLM was 57.5%, and the median survival time was 25 months. Univariate analysis clarified that the significant prognostic factors for poor survival were the depth of primary colorectal cancer (> serosal invasion), hepatic resection margin (< 5 mm), presence of portal vein invasion of CRCLM, and the presence of intra- and extrahepatic recurrence. Multivariate analysis indicated the presence of intra- and extrahepatic recurrence as the independent predictive factors for poor prognosis. The risk factors for intrahepatic recurrence were resection margin (< 5 mm) of CRCLM, while no risk factor for extrahepatic recurrence was noted. In subgroup with synchronous CRCLM, combination of surgery and adjuvant chemotherapy controlled intrahepatic recurrence and improve the prognosis significantly.
Conclusions
Optimal surgical strategies in conjunction with effective chemotherapeutic regimens need to be established in patients with risk factors for recurrence and poor outcome listed above.
Similar Posts:
- The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the EnRoute+ Study
- Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial)
- Analysis on the clinical features of 22 basaloid squamous cell carcinoma of the lung
- Safety of liver resection and effect on quality of life in patients with benign hepatic disease: Single center experience
- Active Faith Predicts Survival After Liver Transplant (CME/CE)